What is IOL Chemicals And Pharmaceuticals Gross Margin %?
IOL Chemicals And PharmaceuticalsNSE:IOLCP +2.06%68 Gross Margin % is 39.90% as of Mar. 2026, which is 21% above its 10-year median of 32.95. GuruFocus rates NSE:IOLCP with a GF Score™ of 68/100 and a GF Value™ of ₹93.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 938 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks worse than 71.96% on this metric.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
IOL Chemicals And Pharmaceuticals had a gross margin of 39.90% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
IOL Chemicals And Pharmaceuticals Gross Margin % Related Terms
IOL Chemicals And Pharmaceuticals Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOL Chemicals And Pharmaceuticals Gross Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IOL Chemicals And Pharmaceuticals Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Gross Margin % distribution charts can be found below:
* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Gross Margin % of 39.90% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. This is 21% above median its historical median of 32.95. Over the past decade, IOL Chemicals And Pharmaceuticals' Gross Margin % has ranged from 26.05 to 42.24. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #675 out of 938 companies in the Drug Manufacturers industry, placing it in the top 72%.
Is IOL Chemicals And Pharmaceuticals' Gross Margin % too high?
IOL Chemicals And Pharmaceuticals' current Gross Margin % of 39.90% is 21% above median its 10-year median of 32.95. Over the past 10 years, this metric has ranged from a low of 26.05 to a high of 42.24. The Drug Manufacturers industry median Gross Margin % is 48.44. IOL Chemicals And Pharmaceuticals' value of 39.90% is 17.6% below this industry median. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #675 out of 938 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #675 out of 938 companies for Gross Margin %. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. The industry median Gross Margin % is 48.44. IOL Chemicals And Pharmaceuticals' value of 39.90% is 17.6% below this benchmark. Historically, IOL Chemicals And Pharmaceuticals' own Gross Margin % has ranged from 26.05 to 42.24 over the past decade. While the company's 10-year median is 32.95 vs. the industry median of 48.44, IOL Chemicals And Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IOL Chemicals And Pharmaceuticals's current Gross Margin % of 39.90% is 17.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IOL Chemicals And Pharmaceuticals's current Gross Margin % is 39.90%, which is 21% above median its own 10-year median of 32.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.62, compared to a current price of ₹133.66 — trading 42.8% above its estimated fair value. The current Gross Margin % is 39.90%, which is 21% above median its 10-year median of 32.95 and 17.6% below the Drug Manufacturers industry median of 48.44. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Gross Margin % is 39.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹133.66 is trading 42.8% above its estimated GF Value™ of ₹93.62.
GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:IOLCP:
Gross Margin %: 39.90% (21% above median its 10-year median of 32.95)
GF Value™: ₹93.62 vs. price of ₹133.66 (42.8% above fair value)
Industry Position: 17.6% below the Drug Manufacturers median (#675 of 938)
No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IOL Chemicals And Pharmaceuticals Business Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
68GF Score
Get the complete analysis for NSE:IOLCP
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:IOLCP has been successfully added to your 
